[Significance of lung function study in clinical monitoring of patients with mucoviscidosis].
Lung function tests as tools in the lifelong care of patients with cystic fibrosis can help to assess results of different therapeutic regimes and the prognosis, as there is a typical sequence of alterations of lung function parameters. They allow to assess the degree of disablement more precisely and more adequately than do clinical data; this is of special concern in questions related to social rehabilitation and the finding of an adequate job. Appropriate parameters are forced vital capacity, maximal mid-exspiratory flow, residual volume and partial pressure of oxygen and carbon dioxide in arterial blood.
D002245:Carbon Dioxide / Q000097:blood; D002648:Child; D003550:Cystic Fibrosis / Q000175:diagnosis* / Q000503:physiopathology; D005500:Follow-Up Studies; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008176:Lung Volume Measurements; D010100:Oxygen / Q000097:blood; D012129:Respiratory Function Tests; D013147:Spirometry
D002245:Carbon Dioxide; D010100:Oxygen
Bedeutung der Lungenfunktionsuntersuchung in der klinischen Betreuung von Patienten mit Mucoviscidose.